Tuberculosis and Pregnancy (Review)

Read full text Summarise with VIRAT
Authors: Анна Сергіївна Шаповалова, R.F. Aliiev, Олена Іллівна Глухова, R.F. Aliiev, T.Yu. Aliieva
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective — to analyse current literature on the diagnosis and treatment of tuberculosis in pregnant women. Materials and methods. The study used analytical and bibliosemantic methods. A search in the Google Scholar and PubMed databases was conducted using the keywords «tuberculosis», «pregnancy», «diagnosis of tuberculosis in pregnant women», «treatment of tuberculosis in pregnant women». Results and discussion. Tuberculosis is a major public health problem worldwide. Although tuberculosis during pregnancy is not associated with an increased risk of congenital abnormalities, it can worsen during pregnancy and progress in the postpartum period due to endocrine changes, blood loss, lactation, emotional stress, inadequate treatment or complete absence of treatment for tuberculosis during pregnancy. During this time, a woman can develop both pulmonary and extrapulmonary tuberculosis. Diagnosis of this disease in pregnant women is difficult, as some non-specific symptoms are common to both tuberculosis and pregnancy, such as shortness of breath, fatigue and weakness. Detection of tuberculosis cases in pregnant women can be improved by using new technologies such as digital radiography and molecular diagnostics (Xpert MTB/RIF, Xpert MTB/XDR), risk assessment and initiation of preventive treatment if necessary.Early detection and treatment of active disease can reduce maternal and neonatal morbidity and mortality. Untreated tuberculosis in pregnant women is more dangerous to the mother and fetus than the use of specific treatment.There is no consensus on the optimal treatment regimen for tuberculosis in pregnant women, therefore studies are required to determine the efficacy, safety, tolerability and outcomes for the mother and fetus. The first-line drugs — isoniazid, rifampicin, ethambutol and pyrazinamide — are considered relatively safe.Potentially dangerous second-line drugs due to possible teratogenicity include prothionamide-ethiona­mide, pretomanid, aminoglycosides, fluoroquinolones, linezolid, clofazimine, terizidone and delamanid.It is generally accepted that in pregnant women with active tuberculosis, chemotherapy should be started immediately, regardless of the gestational age. The decision to postpone the start of treatment is made jointly by the doctor and the patient after assessment of the risks and benefits of chemotherapy. Conclusions. The problem of tuberculosis in pregnant women remains relevant and should not be ignored by clinicians and researchers. Timely rapid diagnosis and treatment will help detect tuberculosis in the early stages and treatment will reduce the harmful effects of this disease on the health of the woman and the child.

Fields of Study & Subjects

Tuberculosis Research and Epidemiology Infectious Diseases and Tuberculosis Diagnosis and treatment of tuberculosis

Publication details

Journal / source
Tuberculosis Lung Diseases HIV Infection
Issue
1
Pages
100–105
Publication date
26 March 2026
Language
EN